<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34596984</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.</ArticleTitle><Pagination><StartPage>46</StartPage><EndPage>54</EndPage><MedlinePgn>46-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000001939</ELocationID><Abstract><AbstractText Label="BACKGROUND">Few studies have addressed the functional impact after transanal total mesorectal excision.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to evaluate function and health-related quality of life among patients with rectal cancer treated with transanal total mesorectal excision.</AbstractText><AbstractText Label="DESIGN">Consecutive patients treated between 2016 and 2018 were selected. Their function and quality of life were studied preoperatively and at 3 and 12 months after surgery.</AbstractText><AbstractText Label="SETTING">This is a prospective case series.</AbstractText><AbstractText Label="PATIENTS">Patients were eligible if they had primary anastomosis, their diverting stoma had been reversed, and they did not have anastomotic leakage. Forty-five patients were finally included. A total of 31 (68.8%) and 32 patients (71.1%) completed the 3- and 12-month surveys.</AbstractText><AbstractText Label="INTERVENTIONS">Standard transanal total mesorectal excision was performed.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary end point was functional and quality-of-life outcomes using validated questionnaires. Secondary end points included values obtained with endoanal ultrasounds, anorectal manometries, and rectal sensation testing.</AbstractText><AbstractText Label="RESULTS">Wexner and Low Anterior Resection Syndrome scores significantly increased 3 months after surgery but returned to baseline values at 12 months. The rate of "major low anterior resection syndrome" at the end of follow-up was 25.0% (+11.7% compared with baseline, p = 0.314). Sexual and urinary functions remained stable throughout the study, although a meaningful clinical improvement was detected in male sexual interest. Among quality-of-life domains, all deteriorations returned to baseline values 12 months after surgery, except worsening of flatulence symptoms, and improvement in insomnia and constipation. At 12 months, an expected decrease in the mean width of the internal sphincter, the anal resting pressure, and the tenesmus threshold volume was found.</AbstractText><AbstractText Label="LIMITATIONS">This study was limited by its small sample size, the absence of a comparative group, and significant missing data in female sexual difficulty and in ultrasounds and manometries at 3 months.</AbstractText><AbstractText Label="CONCLUSIONS">Patients undergoing transanal total mesorectal excision report acceptable quality-of-life and functional outcomes 12 months after surgery. See Video Abstract at http://links.lww.com/DCR/B541.</AbstractText><AbstractText Label="RESULTADOS FUNCIONALES Y CALIDAD DE VIDA DE LOS PACIENTES DESPUS DE LA ESCISIN MESORRECTAL TOTAL TRANSANAL PARA CNCER DE RECTO UN ESTUDIO PROSPECTIVO OBSERVACIONAL">ANTECEDENTES:Pocos estudios han abordado el impacto funcional despu&#xe9;s de la escisi&#xf3;n mesorrectal total transanal.OBJETIVO:Evaluar la funci&#xf3;n y la calidad de vida relacionada con la salud en pacientes con c&#xe1;ncer de recto tratados con escisi&#xf3;n mesorrectal total transanal.DISE&#xd1;O:Se seleccionaron pacientes consecutivos tratados entre 2016 y 2018. Se estudi&#xf3; su funci&#xf3;n y calidad de vida, en la etapa preoperatoria, a los tres y doce meses postoperatorios.METODO:Serie de casos prospectivos.PACIENTES:Los pacientes eran incluidos en presencia de anastomosis primaria, cierre del estoma de derivaci&#xf3;n y en ausencia de fuga anastom&#xf3;tica. Finalmente se incluyeron cuarenta y cinco pacientes. Un total de 31 (68,8%) y 32 pacientes (71,1%) completaron las encuestas de tres y doce meses, respectivamente.INTERVENCIONES:Escisi&#xf3;n mesorrectal total transanal est&#xe1;ndar.PRINCIPALES MEDIDAS DE RESULTADO:Los criterio de evaluaci&#xf3;n principal fueron los resultados funcionales y de calidad de vida mediante cuestionarios previamente validados. Los criterios de evaluaci&#xf3;n secundarios incluyeron los valores obtenidos con ecograf&#xed;a endoanal, manometr&#xed;a anorrectal y prueba de sensibilidad rectal.RESULTADOS:La escala de Wexner y el s&#xed;ndrome de resecci&#xf3;n anterior baja aumentaron significativamente tres meses despu&#xe9;s de la cirug&#xed;a, pero volvieron a los valores iniciales a los doce meses. La tasa de "s&#xed;ndrome de resecci&#xf3;n anterior inferior grave" al final del seguimiento fue del 25,0% (+ 11,7% en comparaci&#xf3;n con el valor inicial, p = 0,314). La funci&#xf3;n sexual y urinaria se mantuvo estable durante todo el estudio, aunque se detect&#xf3; una mejora cl&#xed;nica significativa en la libido masculina. Entre los criterios que eval&#xfa;an la calidad de vida, todas las alteraciones en la misma volvieron a los valores iniciales, doce meses despu&#xe9;s de la cirug&#xed;a, excepto el aumento de flatulencia, la mejor&#xed;a del insomnio y el estre&#xf1;imiento. A los doce meses, se encontr&#xf3; una disminuci&#xf3;n esperada en el grosor medio del esf&#xed;nter interno, la presi&#xf3;n anal en reposo y el volumen umbral para la presencia de tenesmo.LIMITACIONES:Tama&#xf1;o de muestra limitado, ausencia de un grupo comparativo, falta significativa de datos para identificar la dificultad para la actividad sexual femenina y el efectuar ecograf&#xed;a y manometr&#xed;a a los tres meses.CONCLUSIONES:Los pacientes sometidos a escisi&#xf3;n mesorrectal total transanal refieren una calidad de vida y resultados funcionales aceptables a los doce meses despu&#xe9;s de la cirug&#xed;a. Consulte Video Resumen en http://links.lww.com/DCR/B541.</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Lacy</LastName><ForeName>F Borja</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turrado-Rodriguez</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torroella</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Laarhoven</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otero-Pi&#xf1;eiro</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almenara</LastName><ForeName>Ra&#xfa;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacima</LastName><ForeName>Gl&#xf2;ria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castells</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Institute of Digestive and Metabolic Diseases, Hospital Clinic, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), IDIBAPS, University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacy</LastName><ForeName>Antonio M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Hep&#xe1;ticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D057405">Webcast</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019160" MajorTopicYN="N">Endosonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008365" MajorTopicYN="N">Manometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="N">Proctectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="N">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012725" MajorTopicYN="N">Sexual Behavior</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067368" MajorTopicYN="N">Transanal Endoscopic Surgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014554" MajorTopicYN="N">Urination</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Financial Disclosures: Drs Borja de Lacy, Turrado, Torroella, van Laarhoven, Otero-Pi&#xf1;eiro, Almenara, and Lacima have no conflicts of interest or financial ties to disclose. Dr Castells reports personal fees from Amadix, Goodgut and Universal Diagnostics, and grants from SAF2014 and AECC, outside the submitted work. Dr Lacy reports personal fees from Medtronic, Olympus, Applied Medical, and Conmed, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>15</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34596984</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000001939</ArticleId><ArticleId IdType="pii">00003453-202201000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479&#x2013;1482.</Citation></Reference><Reference><Citation>Stewart DB, Dietz DW. Total mesorectal excision: what are we doing? Clin Colon Rectal Surg. 2007;20:190&#x2013;202.</Citation></Reference><Reference><Citation>Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL. Anterior resection syndrome. Lancet Oncol. 2012;13:e403&#x2013;e408.</Citation></Reference><Reference><Citation>Keane C, Wells C, O&#x2019;Grady G, Bissett IP. Defining low anterior resection syndrome: a systematic review of the literature. Colorectal Dis. 2017;19:713&#x2013;722.</Citation></Reference><Reference><Citation>Trenti L, Galvez A, Biondo S, et al. Quality of life and anterior resection syndrome after surgery for mid to low rectal cancer: a cross-sectional study. Eur J Surg Oncol. 2018;44:1031&#x2013;1039.</Citation></Reference><Reference><Citation>Penna M, Hompes R, Arnold S, et al.; TaTME Registry Collaborative. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. 2017;266:111&#x2013;117.</Citation></Reference><Reference><Citation>Larsen SG, Pfeffer F, K&#xf8;rner H; Norwegian Colorectal Cancer Group. Norwegian moratorium on transanal total mesorectal excision. Br J Surg. 2019;106:1120&#x2013;1121.</Citation></Reference><Reference><Citation>Penna M, Hompes R, Arnold S, et al.; International TaTME Registry Collaborative. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the International TaTME Registry. Ann Surg. 2019;269:700&#x2013;711.</Citation></Reference><Reference><Citation>Arroyave MC, DeLacy FB, Lacy AM. Transanal total mesorectal excision (TaTME) for rectal cancer: step by step description of the surgical technique for a two-teams approach. Eur J Surg Oncol. 2017;43:502&#x2013;505.</Citation></Reference><Reference><Citation>van der Heijden JAG, Ko&#xeb;ter T, Smits LJH, et al. Functional complaints and quality of life after transanal total mesorectal excision: a meta-analysis. Br J Surg. 2020;107:489&#x2013;498.</Citation></Reference><Reference><Citation>Luglio G, De Palma GD, Tarquini R, et al. Laparoscopic colorectal surgery in learning curve: role of implementation of a standardized technique and recovery protocol. A cohort study. Ann Med Surg (Lond). 2015;4:89&#x2013;94.</Citation></Reference><Reference><Citation>Bretagnol F, Rullier E, Laurent C, Zerbib F, Gontier R, Saric J. Comparison of functional results and quality of life between intersphincteric resection and conventional coloanal anastomosis for low rectal cancer. Dis Colon Rectum. 2004;47:832&#x2013;838.</Citation></Reference><Reference><Citation>Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922&#x2013;928.</Citation></Reference><Reference><Citation>Giesinger JM, Kieffer JM, Fayers PM, et al.; EORTC Quality of Life Group. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79&#x2013;88.</Citation></Reference><Reference><Citation>Stiggelbout AM, Kunneman M, Baas-Thijssen MC, et al. The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version. Qual Life Res. 2016;25:1853&#x2013;1858.</Citation></Reference><Reference><Citation>Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365&#x2013;376.</Citation></Reference><Reference><Citation>Musoro JZ, Bottomley A, Coens C, et al.; EORTC Melanoma Group and EORTC Quality of Life Group. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma. Eur J Cancer. 2018;104:169&#x2013;181.</Citation></Reference><Reference><Citation>Koedam TW, van Ramshorst GH, Deijen CL, et al. Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol. 2017;21:25&#x2013;33.</Citation></Reference><Reference><Citation>Le&#xe3;o P, Santos C, Goulart A, et al. TaTME: analysis of the evacuatory outcomes and EUS anal sphincter. Minim Invasive Ther Allied Technol. 2019;28:332&#x2013;337.</Citation></Reference><Reference><Citation>Emmertsen KJ, Laurberg S; Rectal Cancer Function Study Group. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100:1377&#x2013;1387.</Citation></Reference><Reference><Citation>Juul T, Ahlberg M, Biondo S, et al. Low anterior resection syndrome and quality of life: an international multicenter study. Dis Colon Rectum. 2014;57:585&#x2013;591.</Citation></Reference><Reference><Citation>Dou R, Sun W, Luo S, Hou Y, Zhang C, Kang L. [Comparison of postoperative bowel function between patients undergoing transanal and laparoscopic total mesorectal excision]. Zhonghua Wei Chang Wai Ke Za Zhi. 2019;22:246&#x2013;254.</Citation></Reference><Reference><Citation>Mora L, Zarate A, Serra-Aracil X, Pallisera A, Serra S, Navarro-Soto S. [Functional impairment and quality of life after rectal cancer surgery]. Cir. 2018;86:140&#x2013;147.</Citation></Reference><Reference><Citation>Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, Rullier E. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Surg Endosc. 2016;30:4924&#x2013;4933.</Citation></Reference><Reference><Citation>Veltcamp Helbach M, Koedam TWA, Knol JJ, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc. 2019;33:79&#x2013;87.</Citation></Reference><Reference><Citation>Bjoern MX, Nielsen S, Perdawood SK. Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg. 2019;23:1623&#x2013;1630.</Citation></Reference><Reference><Citation>Andersson J, Abis G, Gellerstedt M, et al. Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II). Br J Surg. 2014;101:1272&#x2013;1279.</Citation></Reference><Reference><Citation>Andersson J, Angenete E, Gellerstedt M, et al. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial. Br J Surg. 2013;100:941&#x2013;949.</Citation></Reference><Reference><Citation>Schmidt CE, Bestmann B, K&#xfc;chler T, Longo WE, Kremer B. Ten-year historic cohort of quality of life and sexuality in patients with rectal cancer. Dis Colon Rectum. 2005;48:483&#x2013;492.</Citation></Reference><Reference><Citation>Farouk R, Duthie GS, Lee PW, Monson JR. Endosonographic evidence of injury to the internal anal sphincter after low anterior resection: long-term follow-up. Dis Colon Rectum. 1998;41:888&#x2013;891.</Citation></Reference><Reference><Citation>Mora L&#xf3;pez L, Serra-Aracil X, Navarro Soto S. Sphincter lesions observed on ultrasound after transanal endoscopic surgery. World J Gastroenterol. 2015;21:13160&#x2013;13165.</Citation></Reference><Reference><Citation>Speakman CT, Burnett SJ, Kamm MA, Bartram CI. Sphincter injury after anal dilatation demonstrated by anal endosonography. Br J Surg. 1991;78:1429&#x2013;1430.</Citation></Reference><Reference><Citation>Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life after transanal endoscopic microsurgery. Br J Surg. 2011;98:1635&#x2013;1643.</Citation></Reference><Reference><Citation>Mora L&#xf3;pez L, Serra Aracil X, Hermoso Bosch J, Rebasa P, Navarro Soto S. Study of anorectal function after transanal endoscopic surgery. Int J Surg. 2015;13:142&#x2013;147.</Citation></Reference><Reference><Citation>De Nardi P, Testoni SG, Corsetti M, et al. Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer. Dig Liver Dis. 2017;49:91&#x2013;97.</Citation></Reference><Reference><Citation>Hayes RD, Bennett C, Dennerstein L, Gurrin L, Fairley C. Modeling response rates in surveys of female sexual difficulty and dysfunction. J Sex Med. 2007;4:286&#x2013;295.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27391009</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">0717-6384</ISSN><JournalIssue CitedMedium="Internet"><Volume>16 Suppl 2</Volume><PubDate><Year>2016</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Medwave</Title><ISOAbbreviation>Medwave</ISOAbbreviation></Journal><ArticleTitle>Early mobilization versus bed rest for deep vein thrombosis.</ArticleTitle><Pagination><StartPage>e6478</StartPage><MedlinePgn>e6478</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5867/medwave.2016.6478</ELocationID><Abstract><AbstractText>Aiming to prevent thromboembolic events, bed rest was historically considered in the management of patient with deep vein thrombosis. Nevertheless early ambulation could have beneficial effects. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified seven systematic reviews including 10 randomized trials answering this question. We combined the evidence using meta-analysis and generated a summary of findings table following the GRADE approach. We concluded early ambulation is probably effective in reducing deep vein thrombosis progression and improving limb pain, and might not increase the risk of thromboembolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Izcovich</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Cl&#xed;nica M&#xe9;dica, Hospital Alem&#xe1;n, Buenos Aires, Argentina; Programa de Medicina Basada en Pruebas, Hospital Alem&#xe1;n, Buenos Aires, Argentina. Address: Hospital Alem&#xe1;n de Buenos Aires, Av. Pueyrredon 1640, CP C118AAT, +54114827700. Email: federicopopoff@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popoff</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servicio de Cl&#xed;nica M&#xe9;dica, Hospital Alem&#xe1;n, Buenos Aires, Argentina; Programa de Medicina Basada en Pruebas, Hospital Alem&#xe1;n, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rada</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Programa de Salud Basada en Evidencia, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile; Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile; GRADE working group; The Cochrane Collaboration; Fundaci&#xf3;n Epistemonikos, Santiago, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Deambulaci&#xf3;n precoz versus reposo para pacientes con trombosis venosa profunda.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Chile</Country><MedlineTA>Medwave</MedlineTA><NlmUniqueID>101581949</NlmUniqueID><ISSNLinking>0717-6384</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001510" MajorTopicYN="N">Bed Rest</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004434" MajorTopicYN="N">Early Ambulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Hist&#xf3;ricamente el reposo en cama fue incluido como parte del esquema de manejo de pacientes con trombosis venosa profunda con el objetivo de evitar eventos tromboemb&#xf3;licos. Sin embargo, la deambulaci&#xf3;n precoz podr&#xed;a asociarse a beneficios importantes. Utilizando la base de datos Epistemonikos, la cual es mantenida mediante b&#xfa;squedas en 30 bases de datos, identificamos siete revisiones sistem&#xe1;ticas que en conjunto incluyen 10 estudios controlados aleatorizados pertinentes. Realizamos un metan&#xe1;lisis y tablas de resumen de los resultados utilizando el m&#xe9;todo GRADE. Concluimos que la deambulaci&#xf3;n temprana probablemente disminuye el dolor y el riesgo de progresi&#xf3;n de la trombosis, y podr&#xed;a no aumentar el riesgo de tromboembolismo pulmonar.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27391009</ArticleId><ArticleId IdType="doi">10.5867/medwave.2016.6478</ArticleId><ArticleId IdType="pii">e6478</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>